Cargando…

Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL

Objective. To assess the predictive worth of HPV E6/E7 mRNA detection in the outcome of the cervical low-grade squamous intraepithelial lesion (LSIL). From September 2017 to early September 2019, patients screened for high-risk HPV positive or abnormal cervical liquid-based cytology were retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Limei, He, Ping, Yang, Jun, Long, Xin, Chen, Yanqiu, Yan, Li, Zhou, Deping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377884/ https://www.ncbi.nlm.nih.gov/pubmed/35978997 http://dx.doi.org/10.1155/2022/8747919

Ejemplares similares

Retracted: Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer
por: Xu, Yating, et al.
Publicado: (2023)

Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma
por: Wu, Ming-Zhe, et al.
Publicado: (2018)

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
por: Zhang, Shao-Kai, et al.
Publicado: (2020)

Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
por: Jin, Xiu, et al.
Publicado: (2023)

Performance of Aptima HPV E6/E7 mRNA Test for Detection of Cervical Lesions in a Large Chinese Population
por: Yang, Zhujuan, et al.
Publicado: (2022)

HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women
por: Bruno, Maria Teresa, et al.
Publicado: (2018)

Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions
por: Hui, Chang, et al.
Publicado: (2021)

Retrieval of HPV oncogenes E6 and E7 mRNA from cervical specimens using a manual open technology protocol
por: Campbell, Leonardo Martins, et al.
Publicado: (2013)

E6/E7 mRNA Expression of the Most Prevalent High-Risk HPV Genotypes in Cervical Samples from Serbian Women
por: Nikolic, Natasa, et al.
Publicado: (2023)

HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
por: Zhou, Kun, et al.
Publicado: (2023)

HPV E6/E7 mRNA transcripts as predictors of high-grade epithelial cervix dysplasia
por: Möckel, J, et al.
Publicado: (2007)

HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis
por: Luo, Rong-Zhen, et al.
Publicado: (2021)

Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2010)

HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review
por: Derbie, Awoke, et al.
Publicado: (2020)

Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath™ specimens with review of literature
por: Shidham, Vinod B, et al.
Publicado: (2007)

HPV E6/E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols
por: Sharma, Bhawna, et al.
Publicado: (2022)

Prognostic Value of DNA and mRNA E6/E7 of Human Papillomavirus in the Evolution of Cervical Intraepithelial Neoplasia Grade 2
por: Discacciati, Michelle G, et al.
Publicado: (2014)

Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS
por: Zhu, Yuanhang, et al.
Publicado: (2019)

HPV E6, E6AP and cervical cancer
por: Beaudenon, Sylvie, et al.
Publicado: (2008)

Quantification of HPV16 E6/E7 mRNA Spliced Isoforms Viral Load as a Novel Diagnostic Tool for Improving Cervical Cancer Screening
por: Camus, Claire, et al.
Publicado: (2018)

Overexpression of E6/E7 mRNA HPV Is a Prognostic Biomarker for Residual Disease Progression in Women Undergoing LEEP for Cervical Intraepithelial Neoplasia 3
por: Bruno, Maria Teresa, et al.
Publicado: (2023)

Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
por: So, Kyeong A, et al.
Publicado: (2018)

Preliminary study of the use of E6/E7mRNA detection in screening and triage management of HR-HPV infection during pregnancy
por: Yang, Yong-Mei, et al.
Publicado: (2021)

The Value of Immunocytochemical Staining for the HPV E7 Protein in the Diagnosis of Cervical Lesions
por: Fei, Mingjian, et al.
Publicado: (2023)

Prognostic Value of HPV E6/E7 mRNA Assay in Women with Negative Colposcopy or CIN1 Histology Result: A Follow-Up Study
por: Giorgi Rossi, Paolo, et al.
Publicado: (2013)

HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR Assay for Detecting High-Grade Cervical Lesion with Microscope Slides
por: Kim, Geehyuk, et al.
Publicado: (2019)

Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
por: Liu, Ying, et al.
Publicado: (2023)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

HPV test results and histological follow-up results of patients with LSIL Cervical Cytology from the Largest CAP-certified laboratory in China
por: Zheng, Baowen, et al.
Publicado: (2017)

KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells
por: Dai, Lu, et al.
Publicado: (2017)

Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women
por: Bruno, Maria Teresa, et al.
Publicado: (2022)

Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study
por: Ren, Chenchen, et al.
Publicado: (2019)

The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells
por: Wu, Ming-Zhe, et al.
Publicado: (2018)

Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System
por: Alrajjal, Ahmed, et al.
Publicado: (2021)

The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL
por: Liu, Jixuan, et al.
Publicado: (2022)

HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes
por: Yuan, Hang, et al.
Publicado: (2017)

Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
por: Gutiérrez-Hoya, Adriana, et al.
Publicado: (2020)

Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes
por: Sun, Xiaodong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_urvjjd83jjrmmhd8ot8a545pao